Introduction: Stroke is the leading cause of disability worldwide, not only due to motor impairment, but to many sequelae in other domains. Fatigue is one of the most impacting symptoms in the quality of life in post stroke patients, with estimated prevalence around 30%. Objectives and methods: We present a cross-sectional study that aimed to determine the prevalence of fatigue in patients with ischemic stroke followed in the neurovascular outpatient clinic of a tertiary hospital in São Paulo, Brazil, using the Fatigue Assessment Scale (FAS) questionnaire. It can range from 0-50 points, proportional to symptom intensity; scores equal or over 24 points indicate fatigue in such individuals. Casuistics and results: One hundred and fifty seven questionnaires were analyzed and classified according to the FAS. Mean age was 58 years, 74 (47.13%) individuals were men and median FAS score was 21 points (interquartile range: 18–29). Of the interviewees, 64 individuals (40.76%) were classified as having fatigue by the established cut-off; in this subgroup, mean age was 55 years and 28 (43.75%) were men. Discussion and conclusion: In this study, around 40% of post-stroke patients have fatigue, indicating a high prevalence in our population. Fatigue has a high impact on the quality of life of patients, also worsening in functionality and mortality, due to lesser participation in rehabilitation and physical activities. Thus, the health professional dealing with post-stroke patients must be aware and prepared to help patients in coping with fatigue.
Introduction: Chorea is a movement disorder characterized by involuntary, random and irregular movements. In the emergency department, the most common causes of chorea are cerebrovascular disorders, but other conditions may also play an important role. The aim is to present a rare case of acquired hemichorea secondary to hyponatremia by reviewing the patient’s records. Case report: A 73-year-old female patient with a history of arterial hypertension, dyslipidemia, active smoking, and heart failure, taking enalapril, hydrochlorothiazide, furosemide and simvastatin, was admitted to the emergency department after falling from standing height and hitting her head, also presenting choreic movements in the right side of her body. The patient started amitriptyline for chronic low back pain in the last month and had been experiencing apathy and weight loss since; the choreic movements had started a week before admission and had progressively worsened. On admission, the patient presented with fluctuating level of consciousness and hemichorea. Complementary evaluation showed leukocytosis and hyponatremia (117 mg/ dL); magnetic resonance imaging of the brain showed diffuse brain atrophy without any other findings compatible with hemichorea and the lumbar puncture did not reveal any additional findings; a pulmonary infection was detected by the chest computed tomography. The patient was treated for pulmonary infection and hyponatremia. Haloperidol was started, but the chorea was fully solved after hyponatremia correction over the next few days and did not return after haloperidol weaning. Discussion: We presented the case of a 73-year-old woman with acquired hemichorea secondary to hyponatremia, which resolved completely after the metabolic disorder was corrected. Although this condition has been described, its incidence remains unclear, as few cases have been reported.
Introduction: Stroke is the leading cause of disability worldwide. Late complications, such as sexual dysfunction, have a direct impact on psychological and emotional aspects and directly affect the quality of life of these patients. Objectives and methods: We present a cross-sectional study that aimed to determine the prevalence of sexual dysfunction in patients with ischemic stroke followed in the neurovascular outpatient clinic of a tertiary hospital in São Paulo, Brazil, using the Male Sexual Quotient (MSQ) questionnaire. The MSQ can range from 0-100 points. Higher values indicate better sexual performance/satisfaction and a score of 60 points or less was considered as having sexual dysfunction. Casuistics and results: Fifty eight questionnaires were analyzed and classified according to the MSQ score. Mean age was 60 years and median MSQ score was 64 points. Of the interviewees, 24.14% had their sexual performance classified as poor-null, 17.24% of patients had poorunfavorable sexual performance, 6.90% as unfavorable-regular; regulargood and good-great sexual performance were equally found in 25.86% of the subjects. Discussion and conclusion: In this study, almost half of post-stroke men have sexual dysfunction according to MSQ, indicating a high impact of such a condition in the quality of life of our patients due to its prevalence. Thus, the health professional dealing with post-stroke patients must be aware and prepared to help patients in coping with sexual dysfunctions.
Cranioplasty is a common neurosurgical procedure. The main reasons for performing cranioplasty are, in addition to aesthetic correction and protection of the brain, the reestablishment of the adequate flow of cerebrospinal fluid and the prevention of complications inherent to the perpetuation of bone failure. In our institution the patient's autologous bone remains the best method for performing cranioplasty, despite the existence of other heterologous grafts and bone substitutes. Despite representing for us, the best material for cranioplasty, the use of autologous grafting is subject to complications. In this paper, the authors present the case of a patient who underwent cranioplasty with autologous bone that progressed with spontaneous resorption of the bone flap. The authors herein briefly discuss the case and review the literature on the subject, with an emphasis on the factors that can lead to such an outcome.
Introduction: Sequelae are frequent in patients with a history of ischemic stroke and result in decreased quality of life, increase in morbidity, mortality and healthcare costs. One often overlooked complication of ischemic stroke is its association with depression and depressive symptoms. Objectives and methods: This cross-sectional study aims to assess the prevalence of depression and depressive symptoms in patients with previous ischemic stroke followed in the neurovascular outpatient clinic of a tertiary hospital in São Paulo, Brazil, through the application of the Patient Health Questionnaire-9 (PHQ-9) filled in by the patients. Casuistics and results: A total of 173 participated in the study, but only 154 answered all PHQ-9 questions. Mean age was 52 years; 56.82% were women; 44 patients (28.6%) had a score ≥ 10, resulting in sensitivity and specificity for post-stroke depression of 86 and 79% respectively; 118 (68.2%) did not present depression or depressive symptoms before the stroke, 33 (19.1%) had previous symptoms and 22 (12.7%) did not answer this specific question. Discussion and conclusion: The results indicate that depression is an important comorbidity in patients with ischemic stroke. In this cohort, most patients did not have depressive symptoms before the stroke. Further studies are important to better assess this association as well as to determine strategies to prevent and to manage this condition.
SUMMARY Microsurgical clipping is currently the main method of treating cerebral aneurysms, even with the improvement of endovascular therapy techniques in recent years. Treatment aims at complete occlusion of the lesion, which is not always feasible. Although appearing superior to endovascular treatment, microsurgical clipping may present varying percentages of incomplete occlusion. Such incidence may be reduced with the use of intraoperative vascular study. Some classifications were elaborated in an attempt to standardize the characteristics of residual lesions, but the classification criteria and terminology used in the studies remain vague and poorly documented, and there is no consensus for a uniform classification. Thus, there is also no agrément on which residual aneurysms should be treated. The aim of this study is to review the literature on residual lesions after microsurgery to treat cerebral aneurysms and how to proceed with them.
Introduction: Acute stroke is the second most prevalent cause of death in the world and an important cause of disability in adults. Urinary incontinence (UI) is a complication present in the acute and chronic phases of stroke and is a strong predictor of mortality and need for institutional care. Objectives and methods: Cross-sectional study that aimed to evaluate the presence of UI through the International Consultation Questionnaire on Incontinence - Short Form (ICIQ-UI SF) in patients with ischemic stroke followed in the neurovascular outpatient clinic of a tertiary hospital in São Paulo, Brazil. The ICIQ-SF assesses the impact of UI on quality of life and qualifies degrees of urinary loss. The final score ranges from 0 to 21, with higher values representing greater impact. Casuistics and results: A total of 141 patients adequately answered the questionnaire, among which 75 were female and 66 were male. As for symptoms, 36.87% reported some degree of UI, 40.00% among women and 33.33% among men. The mean ICIQ-UI SF score across all patients was 9.90. For males the mean score was 10.36 and for females it was 9.56. Among symptomatic patients, only 9.21% reported urinary symptoms before the stroke. Discussion: Almost 40% of the patients in the study acquired UI after stroke. This condition prevailed in women, but with less impact compared to men. Urinary incontinence can affect the quality of life of patients, causing psychological, social, physical, economic, personal and sexual relationships. Conclusion: New studies are needed to evaluate prevention and treatment strategies for incontinence in these patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.